The surprising value of boring chats, ‘super El Niño’ and Alzheimer’s evidence reviewed – podcast
Madeleine Finlay sits down with co-host and science editor Ian Sample to discuss three eye-catching stories from the week, including a review into the effectiveness of a new class of Alzheimer’s drug that was once hailed as a game-changer in slowing the progress of the disease.
Also on the agenda is the news that the world could be heading for a ‘super El Niño’ this summer and a study exploring whether conversations about dull topics really are as boring as we expect them to be
https://www.theguardian.com/science/2026/apr/13/hate-small-talk-enjoy-dull-chat-more-than-you-think">Hate small talk?
You may enjoy that ‘dull’ chat more than you think, say researchers
Support the Guardian: http://theguardian.com/sciencepod">theguardian.com/sciencepod
https://www.theguardian.com/science/audio/2026/apr/16/the-surprising-value-of-boring-chats-super-el-nino-and-alzheimers-evidence-reviewed-podcast">Continue reading...Alzheimer's Breakthrough Drugs Questioned
- 'Breakthrough' Alzheimer's drugs unlikely to benefit patients, report suggests | BBC News BBC News —
- Dementia drugs hailed as 'beginning of the end' for Alzheimer's do not work, major report finds Daily Mail —
- Alzheimer's drugs make 'no meaningful difference' RTE —
- 'Breakthrough' Alzheimer's drugs unlikely to benefit patients, report suggests BBC News —
- Much-hyped Alzheimer’s drugs do not help patients, review finds The Straits Times —